Related Experiment Video
Updated: Jul 5, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Escalation Strategies in Cardiogenic Shock: From Early Recognition to Advanced Support
Vanessa Blumer1, Lauren K Barron2, Anthony P Carnicelli3
1Heart Failure Research, Inova Schar Heart and Vascular, Falls Church, VA, USA.
Cardiology Clinics
|July 3, 2026
Summary
Cardiogenic shock has high mortality. Early use of temporary mechanical circulatory support (tMCS) and dedicated shock teams can improve survival rates for patients with cardiogenic shock.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic Shock (CS) is a life-threatening condition with persistently high mortality rates globally.
- Despite advancements in medical technology, survival outcomes for CS patients remain suboptimal.
- Existing data highlight the need for improved management strategies.
Purpose of the Study:
- To review the current literature on escalating care for cardiogenic shock.
- To provide evidence-based recommendations for optimizing patient survival through organized systems of care.
Main Methods:
- Review of current scientific literature on cardiogenic shock management.
- Analysis of real-world observational and registry data.
- Synthesis of findings to propose recommendations for care escalation.
Main Results:
- Protocolized early use of temporary mechanical circulatory support (tMCS) shows promise in acute myocardial infarction-cardiogenic shock (AMI-CS).
- Real-world data suggest benefits from dedicated shock teams, early tMCS escalation, and hemodynamic/hemometabolic monitoring.
- Opportunities exist to improve survival across various CS etiologies.
Conclusions:
- Implementing organized systems of care, including shock teams and early tMCS, is crucial for improving cardiogenic shock survival.
- Hemodynamic and hemometabolic monitoring are key components of effective CS management.
- Further research and implementation of these strategies are warranted to reduce CS mortality.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.